Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis

被引:3
|
作者
Butcher, Steele C. [1 ,2 ]
Vos, Jacqueline L. [3 ]
Fortuni, Federico [1 ,4 ]
Galloo, Xavier [1 ,5 ]
Liem, Sophie I. E. [6 ]
Bax, Jeroen J. [1 ,7 ,8 ]
Delgado, Victoria [1 ,9 ]
Vonk, Madelon C. [10 ]
van Leuven, Sander, I [10 ]
Snoeren, Miranda [11 ]
El Messaoudi, Saloua [3 ]
de Vries-Bouwstra, Jeska K. [6 ]
Nijveldt, Robin [3 ]
Ajmone Marsan, Nina [1 ]
机构
[1] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands
[2] Royal Perth Hosp, Dept Cardiol, Perth, WA, Australia
[3] Radboud UMC, Cardiol, Nijmegen, Netherlands
[4] San Giovanni Battista Hosp, Dept Cardiol, Foligno, Italy
[5] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Cardiol, Brussels, Belgium
[6] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[7] Univ Turku, Heart Ctr, Turku, Finland
[8] Turku Univ Hosp, Turku, Finland
[9] Univ Hosp Germans Trias & Pujol, Heart Inst, Badalona, Spain
[10] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands
[11] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, Nijmegen, Netherlands
关键词
left atrial; ventricular; strain; CMR; feature-tracking; SSc; PRESERVED EJECTION FRACTION; SPECKLE-TRACKING; EUROPEAN ASSOCIATION; PREDICTS MORTALITY; STRAIN; ECHOCARDIOGRAPHY;
D O I
10.1093/rheumatology/keac256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to determine whether lower values of feature-tracking cardiovascular magnetic resonance (CMR)-derived left atrial reservoir strain (LARS) and impaired left ventricular (LV) global longitudinal strain (GLS) were associated with the presence of symptoms and long-term prognosis in patients with SSc. Methods A total of 100 patients {54 [interquartile range (IQR) 46-64] years, 42% male} with SSc who underwent CMR imaging at two tertiary referral centres were included. All patients underwent analysis of LARS and LV GLS using feature-tracking on CMR and were followed-up for the occurrence of all-cause mortality. Results The median LV GLS was -21.8% and the median LARS was 36%. On multivariable logistic regression, LARS [odds ratio (OR) 0.964 per %, 95% CI 0.929, 0.998, P = 0.049] was independently associated with New York Heart Association (NYHA) class II-IV heart failure symptoms. Over a median follow-up of 37 (21-62) months, a total of 24 (24%) patients died. Univariable Cox regression analysis demonstrated that LARS [hazard ratio (HR) 0.94 per 1%, 95% CI 0.91, 0.97, P < 0.0001) and LV GLS (HR 1.10 per %, 95% CI 1.03, 1.17, P = 0.005) were associated with all-cause mortality, while LV ejection fraction was not. Likelihood ratio tests demonstrated that LARS provided incremental value over prognostically important clinical and imaging parameters, including late gadolinium enhancement. Conclusion In patients with SSc, LARS was independently associated with the presence of NYHA class II-IV heart failure symptoms. Although both LARS and LV GLS were associated with all-cause mortality, only LARS provided incremental value over all evaluated variables known to be prognostically important in patients with SSc.
引用
收藏
页码:SI20 / SI31
页数:12
相关论文
共 50 条
  • [1] Left ventricular diastolic function with cardiac magnetic resonance imaging in systemic sclerosis patients
    Agoston-Coldea, L.
    Marjanovic, Z.
    Kachenoura, N.
    Lupu, S.
    Farge-Bancel, D.
    Mousseaux, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 392 - 392
  • [2] Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms
    Meduri, A.
    Di Molfetta, D. V.
    Natale, L.
    Manfredi, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (21) : 4797 - 4803
  • [3] CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Silvers, S.
    Vignaux, O.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S87 - S87
  • [4] CARDIAC INVOLVEMENT IN SYSTEMIC SCLEROSIS - THE ADDED VALUE OF CARDIAC MAGNETIC RESONANCE
    Gogulska, Z.
    Smolenska, Z.
    Wojteczek, A.
    Viti, A.
    Kulawiak-Galaska, D.
    Zdrojewski, Z.
    Dorniak, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 750 - 750
  • [5] Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms: do we really need it?
    De Luca, G.
    Campochiaro, C.
    Cavalli, G.
    Dagna, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (08) : 2189 - 2190
  • [6] Prognostic value of cardiac magnetic resonance in systemic sclerosis
    Pepe, A.
    Meloni, A.
    Bruni, C.
    De Marchi, D.
    Todiere, G.
    Fulgenzi, F.
    Ghebru, Y.
    Guiducci, S.
    De Caterina, R.
    Cerinic, Matucci M.
    Gargani, L.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 : 81 - +
  • [7] PROGNOSTIC VALUE OF CARDIAC MAGNETIC RESONANCE IN SYSTEMIC SCLEROSIS
    Bruni, Cosimo
    Gargani, Luna
    Pepe, Alessia
    Meloni, Antonella
    De Marchi, Daniele
    Todiere, Giancarlo
    Fulgenzi, Fabio
    Ghebru, Yacob
    Guiducci, Serena
    De Caterina, Raffaele
    Matucci-Cerinic, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1203 - 1203
  • [8] The emerging role of cardiovascular magnetic resonance in the evaluation of cardiac involvement in systemic sclerosis
    Mavrogeni, Sophie I.
    Pepe, Alessia
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (02): : 93 - 98
  • [9] Evaluation of left ventricular function using cardiac magnetic resonance imaging
    Grover, Suchi
    Leong, Darryl P.
    Selvanayagam, Joseph B.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (02) : 351 - 365
  • [10] Evaluation of left ventricular function using cardiac magnetic resonance imaging
    Suchi Grover
    Darryl P. Leong
    Joseph B. Selvanayagam
    Journal of Nuclear Cardiology, 2011, 18 : 351 - 365